Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 29.87 | 34.81 | 26.64 | 21.87 |
Depreciation/ Depletion | 1.66 | 1.21 | 1.53 | 1.09 |
Non- Cash Items | 6.61 | 8.04 | -2.93 | -1.95 |
Changesin Working Capital | -2.97 | 2.60 | -18.33 | 8.44 |
Cashfrom Operating Activities | 35.17 | 46.66 | 6.91 | 28.22 |
Capital Expenditures | -0.25 | -0.32 | -1.05 | -0.47 |
Other Investing Cash Flow Items Total | -24.30 | -57.35 | -24.73 | -1.80 |
Cashfrom Investing Activities | -24.55 | -57.67 | -25.78 | -2.26 |
Financing Cash Flow Items | -0.81 | -0.14 | -0.29 | -0.51 |
Total Cash Dividends Paid | -13.10 | 0.00 | -10.48 | -2.62 |
Issuance( Retirement)of Stock Net | 5.64 | - | - | -3.69 |
Issuance( Retirement)of Debt Net | -0.63 | -0.32 | -6.79 | - |
Cashfrom Financing Activities | -8.91 | -0.46 | -17.55 | -6.83 |
Net Changein Cash | 1.71 | -11.47 | -36.42 | 19.13 |
Cash Interest Paid | 0.78 | - | - | - |
Cash Taxes Paid | 8.51 | 7.28 | 6.87 | 3.15 |
Deferred Taxes | - | - | - | -12.33 |
Jagsonpal Pharmaceuticals Dividend Jagsonpal Pharmaceuticals Bonus Jagsonpal Pharmaceuticals News Jagsonpal Pharmaceuticals AGM Jagsonpal Pharmaceuticals Rights Jagsonpal Pharmaceuticals Splits Jagsonpal Pharmaceuticals Board Meetings Jagsonpal Pharmaceuticals Key Metrics Jagsonpal Pharmaceuticals Shareholdings Jagsonpal Pharmaceuticals Profit Loss Jagsonpal Pharmaceuticals Balance Sheet Jagsonpal Pharmaceuticals Q1 Results Jagsonpal Pharmaceuticals Q2 Results Jagsonpal Pharmaceuticals Q3 Results Jagsonpal Pharmaceuticals Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks